PT  - JOURNAL ARTICLE
AU  - Lin, Liang-Yu
AU  - Henderson, Alasdair D
AU  - Carlile, Oliver
AU  - Dillingham, Iain
AU  - Butler-Cole, Ben FC
AU  - Marks, Michael
AU  - Briggs, Andrew
AU  - Jit, Mark
AU  - Tomlinson, Laurie A
AU  - Bates, Chris
AU  - Parry, John
AU  - Bacon, Sebastian CJ
AU  - Goldacre, Ben
AU  - Mehrkar, Amir
AU  - MacKenna, Brian
AU - The OpenSAFELY Collaborative
AU  - Eggo, Rosalind M
AU  - Herrett, Emily
TI  - Healthcare utilisation in people with long COVID: an OpenSAFELY cohort study
AID  - 10.1101/2023.12.21.23300305
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.12.21.23300305
4099  - http://medrxiv.org/content/early/2023/12/24/2023.12.21.23300305.short
4100  - http://medrxiv.org/content/early/2023/12/24/2023.12.21.23300305.full
AB  - Background Long COVID, characterised by various symptoms and complications, potentially increases healthcare utilisation and costs. However, its impact on the NHS remains to be determined.Objective This study aims to assess the healthcare utilisation of individuals with long COVID.Methods With the approval of NHS England, we conducted a matched cohort study using primary and secondary care data via OpenSAFELY, a platform for analysing anonymous electronic health records. The long COVID exposure group, defined by diagnostic codes, was matched with five comparators without long COVID between Nov 2020 and Jan 2023. We compared their total healthcare utilisation from GP consultations, prescriptions, hospital admissions, A&E visits, and outpatient appointments. Healthcare utilisation and costs were evaluated using a two-part model adjusting for covariates. Using a difference-in-difference model, we also compared healthcare utilisation after long COVID with pre-pandemic records.Results We identified 52,988 individuals with a long COVID diagnosis, matched to 264,867 comparators without a diagnosis. In the 12 months post-diagnosis, there was strong evidence that those with long COVID were more likely to use healthcare resources (OR: 8.07, 95% CI: 7.54 – 8.64), and have 49% more healthcare utilisation (RR: 1.49, 95% CI: 1.47 – 1.50). Our model estimated that the long COVID group had 30 healthcare visits per year (predicted mean: 29.23, 95% CI: 28.58 - 29.92), compared to 16 in the comparator group (predicted mean visits: 16.04, 95% CI: 15.73 - 16.36). Individuals with long COVID were more likely to have non-zero healthcare expenditures (OR = 7.47, 95% CI = 7.02 – 7.95), with costs being 43% higher than the comparator group (cost ratio = 1.43, 95% CI: 1.38 – 1.49). The long COVID group costs approximately £2,500 per person per year (predicted mean cost: £2,562.50, 95% CI: £2,335.60 - £2,819.22), and the comparator group costs £1,500 (predicted mean cost: £1,527.43, 95% CI: £1,404.33 - 1,664.45.) Historically, individuals with long COVID utilised healthcare resources more frequently, but their average healthcare utilisation increased more after being diagnosed with long COVID, compared to the comparator group.Conclusion Long COVID increases healthcare utilisation and costs. Public health policies should allocate more resources towards preventing, treating, and supporting individuals with long COVID.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://github.com/opensafely/openprompt_health_utilisation/blob/cd8ecce1e12018756375013cd3b27a25880d85a4/OpenPROMPT_longCOVID_healthcare_utilisation_protocol.pdf Funding StatementThis research was supported by the National Institute for Health and Care Research (NIHR) (OpenPROMPT: COV-LT2-0073)). In addition, this research used data assets made available as part of the Data and Connectivity National Core Study, led by Health Data Research UK in partnership with the Office for National Statistics and funded by UK Research and Innovation (grant ref MC_PC_20058). In addition, the OpenSAFELY Platform is supported by grants from the Wellcome Trust (222097/Z/20/Z); MRC (MR/V015737/1, MC_PC-20059, MR/W016729/1); NIHR (NIHR135559, COV-LT2-0073), and Health Data Research UK (HDRUK2021.000, 2021.0157).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:London School of Hygiene & Tropical Medicine Research Ethics Committee gave ethical approval for this work(ref 28030)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll analytic codes are available online at GitHub https://github.com/opensafely/openprompt_health_utilisation